RI-MUHC team detects impact of HIV antiretroviral therapy on the anti-tuberculosis immune response
Alveolar macrophages, cells important for protection from tuberculosis infection, are adversely impacted by...
The 2021 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz
RI-MUHC researchers tackle COVID-19 vaccine hesitancy in adults and in children
Videos from projects led by Drs. Inés Colmegna and Moshe Ben-Shoshan are now available
Research trainees are bridging the gap between science and the public
Two RI-MUHC research trainees share their experience as community outreach panelists
RI-MUHC researcher Sasha Bernatsky leads nationwide COVID-19 vaccination study
New study will assess impact of the vaccines on Canadians with immune-mediated inflammatory disease
App-based HIV self-testing program leads to rapid detection of new infections and efficient connection to care
A unique new study shows that self-testing with the HIVSmart! program...
“An opportunity to give back” through two WHO committees
RI-MUHC researcher Dr. Madhukar Pai is focused on global efforts to improve TB diagnosis and end TB
Two RI-MUHC trainees receive 2021 Vanier Canada Graduate Scholarships
Congratulations to Anish Arora and Motahareh Vameghestahbanati!
RI-MUHC trainee wins award at Canadian Society of Nephrology meeting
Congratulations to Tho-Alfakar Al-Aubodah!
Does the COVID-19 vaccine work for people living with HIV?
RI-MUHC scientist Dr. Cecilia Costiniuk is co-principal investigator in a new national study that hopes to answer critical questions around the...